Could S-1-based non-platinum doublet chemotherapy be a new option as a second-line treatment for advanced non-small cell lung cancer patients? A multicenter retrospective study.
第一作者:
Xiangling,Wang
第一单位:
Department of Medical Oncology, Qilu Hospital of Shandong University, Jinan, China.
作者:
DOI
10.3389/fonc.2023.1089234
PMID
37007066
发布时间
2023-04-04
- 浏览0
Frontiers in oncology
1089234页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文